Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-07 @ 6:45 AM
Study NCT ID:
NCT02047058
Status:
UNKNOWN
Last Update Posted:
2014-01-28
First Post:
2014-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Study Overview
Official Title:
A Multi-center, Prospective, Observational Study of Analysis of Q Cell Markers in Patients With Newly Diagnosed Primary Glioblastoma (Phase IV)
Status:
UNKNOWN
Status Verified Date:
2014-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether Q cells separated from the glioma sample are determinants in treatment response and prognosis of glioma patients
Detailed Description:
The unique markers of Qcell were screened using the method of genomics and
proteomics, then these markers will be qualitatively and quantitatively evaluated in
glioblastoma patients by comparing their relationship with overrall
survival/progression-free survival and treatment response.
proteomics, then these markers will be qualitatively and quantitatively evaluated in
glioblastoma patients by comparing their relationship with overrall
survival/progression-free survival and treatment response.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: